Jul 2026
Abstract A014: Targeting shared metabolic vulnerabilities in IDH-mutant gliomas and colorectal cancer: a new therapeutic angle for rare brain tumors
Dual blockade of mutant IDH and glutaminolysis represents a novel, cross-entity therapeutic regimen and offers a promising treatment avenue for rare, surgically challenging IDH-mutant gliomas.
Lei Li
· Cancer Research · 0 citations